{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:04:32Z","timestamp":1791846272908,"version":"4.3.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["N 817938"],"award-info":[{"award-number":["N 817938"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12K0323N"],"award-info":[{"award-number":["12K0323N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.biomaterials.2024.122693","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T18:16:13Z","timestamp":1719512173000},"page":"122693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["CO-DELIVERY of glutamic acid-extended peptide antigen and imidazoquinoline TLR7\/8 agonist via ionizable lipid nanoparticles induces protective anti-tumor immunity"],"prefix":"10.1016","volume":"311","author":[{"given":"Tingting","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5915-1618","authenticated-orcid":false,"given":"Zifu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4610-4222","authenticated-orcid":false,"given":"Federica","family":"Cappellesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-6973","authenticated-orcid":false,"given":"Kim","family":"Deswarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen","family":"Lauwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"De Lombaerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7613-5137","authenticated-orcid":false,"given":"Mark","family":"Gontsarik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Lienenklaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien","family":"Van Lysebetten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4585-0343","authenticated-orcid":false,"given":"Niek N.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart N.","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan","family":"De Koker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damya","family":"Laoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9826-6170","authenticated-orcid":false,"given":"Bruno G.","family":"De Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2024.122693_bib1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nchembio.477","article-title":"Grand challenge commentary: synthetic immunology to engineer human immunity","volume":"6","author":"Spiegel","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2017.05.011","article-title":"Delivering safer immunotherapies for cancer","volume":"114","author":"Milling","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2024.122693_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc3930","article-title":"Building better monoclonal antibody-based therapeutics","volume":"156 15","author":"Weiner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2024.122693_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/cb500079s","article-title":"Directing the immune system with chemical compounds","volume":"9","author":"Mancini","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI80009","article-title":"Therapeutic cancer vaccines","volume":"125","author":"Melief","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biomaterials.2024.122693_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1158\/0008-5472.CAN-17-1980","article-title":"Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments","volume":"78","author":"Cauwels","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2024.122693_bib7","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2024.122693_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.aaa3828","article-title":"A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2024.122693_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2024.122693_bib10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/0008-5472.CAN-11-3722","article-title":"Exploiting the mutanome for tumor vaccination","volume":"72","author":"Castle","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2024.122693_bib11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2024.122693_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cis.2015.01.007","article-title":"Understanding nanoparticle cellular entry: a physicochemical perspective","volume":"218","author":"Beddoes","year":"2015","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.biomaterials.2024.122693_bib13","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1021\/acs.chemrev.5b00109","article-title":"Synthetic nanoparticles for vaccines and immunotherapy","volume":"115","author":"Irvine","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2024.122693_bib14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2014.04.054","article-title":"TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation","volume":"158","author":"Nair-Gupta","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2024.122693_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2024.122693_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.addr.2016.04.001","article-title":"Lipid-based nanocarriers for oral peptide delivery","volume":"106","author":"Niu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2024.122693_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nmat4822","article-title":"Designer vaccine nanodiscs for personalized cancer immunotherapy","volume":"16","author":"Kuai","year":"2017","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2024.122693_bib18","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2014.02.027","article-title":"Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release","volume":"32","author":"Ilyinskii","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2024.122693_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nmat2960","article-title":"Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses","volume":"10","author":"Moon","year":"2011","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2024.122693_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2016.02.018","article-title":"Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: a comparative study of cationic liposomes and PLGA nanoparticles","volume":"226","author":"Varypataki","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2024.122693_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2024.122693_bib22","article-title":"A combinatorial library of lipid nanoparticles for RNA delivery to leukocytes","volume":"32","author":"Ramishetti","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2024.122693_bib23","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","article-title":"Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation","volume":"37","author":"Miao","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib24","doi-asserted-by":"crossref","first-page":"19045","DOI":"10.1002\/ange.202008319","article-title":"Current status of COVID\u201019 (Pre)Clinical vaccine development","volume":"132","author":"Ye","year":"2020","journal-title":"Angew. Chem."},{"key":"10.1016\/j.biomaterials.2024.122693_bib25","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1021\/acsami.0c20607","article-title":"Lipid-polyglutamate nanoparticle vaccine platform","volume":"13","author":"Van Lysebetten","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2024.122693_bib26","doi-asserted-by":"crossref","first-page":"14300","DOI":"10.1021\/jacs.8b08595","article-title":"Lymph-Node-targeted immune activation by engineered block copolymer amphiphiles\u2013TLR7\/8 agonist conjugates","volume":"140","author":"Van Herck","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2024.122693_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201803397","article-title":"Nanoparticle-Conjugate TLR7\/8 agonist localized immunotherapy provokes safe antitumoral responses","volume":"30","author":"Nuhn","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2024.122693_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202310623","article-title":"Combinatorial screening of biscarbamate ionizable lipids identifies a low reactogenicity lipid for lipid nanoparticle mRNA delivery","author":"De Lombaerde","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2024.122693_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coi.2005.11.003","article-title":"Priming of T cells by exogenous antigen cross-presented on MHC class I molecules","volume":"18","author":"Shen","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/pharmaceutics11110612","article-title":"The role of nanovaccine in cross-presentation of antigen-presenting cells for the activation of CD8+ T cell responses","volume":"11","author":"Kim","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2024.122693_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41590-020-00810-3","article-title":"Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells","volume":"22","author":"Baharom","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib32","series-title":"Clinical Trials CT115\u2013CT115","article-title":"Abstract CT115: updated survival results of the KEYNOTE-040 study of pembrolizumab vs standard-of-care chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma","author":"Soulieres","year":"2018"},{"key":"10.1016\/j.biomaterials.2024.122693_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/acsbiomaterials.6b00414","article-title":"In vivo expansion of melanoma-specific T cells using microneedle arrays coated with immune-polyelectrolyte multilayers","volume":"3","author":"Zeng","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biomaterials.2024.122693_bib34","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1021\/acsami.6b06275","article-title":"Assembly and immunological processing of polyelectrolyte multilayers composed of antigens and adjuvants","volume":"8","author":"Chiu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2024.122693_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/acscentsci.9b01174","article-title":"Redox-responsive polycondensate neoepitope for enhanced personalized cancer vaccine","volume":"6","author":"Wei","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.biomaterials.2024.122693_bib36","article-title":"Lipid nanoparticle technologies for nucleic acid delivery: a nanoarchitectonics perspective","volume":"12","author":"Ferhan","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2024.122693_bib37","doi-asserted-by":"crossref","first-page":"21733","DOI":"10.1039\/C9NR09347H","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","volume":"11","author":"Kulkarni","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2024.122693_bib38","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1021\/acs.langmuir.2c00430","article-title":"Computational insights into the role of cholesterol in inverted hexagonal phase stabilization and endosomal drug release","volume":"38","author":"Ramezanpour","year":"2022","journal-title":"Langmuir"},{"key":"10.1016\/j.biomaterials.2024.122693_bib39","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1073\/pnas.1520244113","article-title":"Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biomaterials.2024.122693_bib40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.xphs.2021.11.004","article-title":"pH-dependent phase behavior and stability of cationic lipid\u2013mRNA nanoparticles","volume":"111","author":"Larson","year":"2022","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.biomaterials.2024.122693_bib41","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1002\/ange.202013927","article-title":"A systematic study of unsaturation in lipid nanoparticles leads to improved mRNA transfection in vivo","volume":"133","author":"Lee","year":"2021","journal-title":"Angew. Chem."},{"key":"10.1016\/j.biomaterials.2024.122693_bib42","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s42003-021-02441-2","article-title":"Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration","volume":"4","author":"Carrasco","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib43","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1021\/acs.molpharmaceut.9b01182","article-title":"The effect of size and charge of lipid nanoparticles prepared by microfluidic mixing on their lymph node transitivity and distribution","volume":"17","author":"Nakamura","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2024.122693_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2020.06.003","article-title":"Dawn of lipid nanoparticles in lymph node targeting: potential in cancer immunotherapy","volume":"167","author":"Nakamura","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2024.122693_bib45","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41587-019-0390-x","article-title":"Peptide\u2013TLR-7\/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens","volume":"38","author":"Lynn","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib46","doi-asserted-by":"crossref","first-page":"10760","DOI":"10.1002\/anie.201803847","article-title":"FRET monitoring of intracellular ketal hydrolysis in synthetic nanoparticles","volume":"57","author":"Nuhn","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2024.122693_bib47","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1021\/acsami.1c18359","article-title":"Quantifying the endosomal escape of pH-responsive nanoparticles using the split luciferase endosomal escape quantification assay","volume":"14","author":"Beach","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2024.122693_bib48","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.1600816113","article-title":"pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation","volume":"113","author":"Nuhn","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biomaterials.2024.122693_bib49","doi-asserted-by":"crossref","first-page":"15390","DOI":"10.1002\/anie.201905687","article-title":"Potent lymphatic translocation and spatial control over innate immune activation by polymer\u2013lipid amphiphile conjugates of small\u2010molecule TLR7\/8 agonists","volume":"58","author":"De Vrieze","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2024.122693_bib50","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.4049\/jimmunol.0804277","article-title":"Novel reporter mouse reveals constitutive and inflammatory expression of IFN-\u03b2 in vivo","volume":"183","author":"Lienenklaus","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib51","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.4049\/jimmunol.1003208","article-title":"IFN-\u0391 directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity","volume":"186","author":"Terawaki","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib52","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.it.2017.05.005","article-title":"Type I interferon in chronic virus infection and cancer","volume":"38","author":"Snell","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib53","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ejca.2006.01.002","article-title":"Inflammatory chemokines in cancer growth and progression","volume":"42","author":"Rollins","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biomaterials.2024.122693_bib54","doi-asserted-by":"crossref","first-page":"i104","DOI":"10.1136\/ard.2010.140145","article-title":"Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage","volume":"70","author":"Grivennikov","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biomaterials.2024.122693_bib55","doi-asserted-by":"crossref","unstructured":"Propper, D. J. & Balkwill, F. R. Harnessing Cytokines and Chemokines for Cancer Therapy. doi:10.1038\/s41571-021-00588-9.","DOI":"10.1038\/s41571-021-00588-9"},{"key":"10.1016\/j.biomaterials.2024.122693_bib56","article-title":"Correction to engineering strategies for lymph node targeted immune activation","volume":"53","author":"Chen","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biomaterials.2024.122693_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00009","article-title":"Are conventional type 1 dendritic cells critical for protective antitumor immunity and how?","volume":"10","author":"Cancel","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib58","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8\u03b1 + dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2024.122693_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2004.06.014","article-title":"CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions","volume":"21","author":"Ohl","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2024.122693_bib60","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2024.122693_bib61","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2017.52","article-title":"A STING-activating nanovaccine for cancer immunotherapy","volume":"12","author":"Luo","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1471-4906(03)00111-X","article-title":"What's the difference between CD80 and CD86?","volume":"24","author":"Sansom","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.1996.tb00920.x","article-title":"CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model","volume":"153","author":"Gool","year":"1996","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biomaterials.2024.122693_bib64","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cca.2011.11.006","article-title":"Surface markers of lymphocyte activation and markers of cell proliferation","volume":"413","author":"Shipkova","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biomaterials.2024.122693_bib65","doi-asserted-by":"crossref","unstructured":"Yamauchi, T. et al. T-Cell CX3CR1 Expression as a Dynamic Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors. doi:10.1038\/s41467-021-21619-0.","DOI":"10.1038\/s41467-021-21619-0"},{"key":"10.1016\/j.biomaterials.2024.122693_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/acsnano.0c03023","article-title":"Glycan-modified virus-like particles evoke T helper type 1-like immune responses","volume":"15","author":"Alam","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2024.122693_bib67","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib68","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4049\/jimmunol.158.6.2723","article-title":"Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules","volume":"158","author":"Shen","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib69","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.4049\/jimmunol.0804277","article-title":"Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo","volume":"183","author":"Lienenklaus","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib70","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1002\/ange.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic Gene silencing in vivo","volume":"124","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem."},{"key":"10.1016\/j.biomaterials.2024.122693_bib71","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mpo.2950120314","article-title":"Volume doubling measurement of spherical and ellipsoidal tumors","volume":"12","author":"Spears","year":"1984","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.biomaterials.2024.122693_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202200167","article-title":"Tracking the endosomal escape: a closer look at calcein and related reporters","volume":"22","author":"Hausig-Punke","year":"2022","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.biomaterials.2024.122693_bib73","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224002278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224002278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T04:14:10Z","timestamp":1728360850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224002278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":73,"alternative-id":["S0142961224002278"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122693","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CO-DELIVERY of glutamic acid-extended peptide antigen and imidazoquinoline TLR7\/8 agonist via ionizable lipid nanoparticles induces protective anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122693"}}